Oral involvement by Stevens-Johnson Syndrome associated with carbamazepine in an immunosuppressed patient: Case report
J. Oral Diagn
; 8: e20230217, 01 out. 2023. ilus, tab
Article
en En
| LILACS, BBO
| ID: biblio-1571930
Biblioteca responsable:
BR2499
ABSTRACT
Introduction:
Stevens-Johnson syndrome (SJS) is caused by a delayed immune response triggered by the association of genetic and environmental factors. This reaction can be mediated mainly by some drugs.Objective:
The purpose of this article is to report the case of a patient with SJS associated with carbamazepine. Case report A man was hospitalized complaining of odynophagia, whitish plaques in the mouth and swelling of the lips. Clinical examination revealed ulcerated and erosive lesions involving the buccal mucosa, lips, tongue and hard palate. The lips were swollen and with hemorrhagic crusts. Papular and purplish-colored lesions were observed on the skin. The patient reported that the lesions started 10 days ago, coinciding with the start of carbamazepine use. The diagnosis of SJS was established based on clinical information and the patient treated with support therapy.Conclusion:
SJS is a clinical condition that affects the oral mucosa and can be triggered by the use of carbamazepine. (AU)Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
BBO
/
LILACS
Asunto principal:
Carbamazepina
/
Síndrome de Stevens-Johnson
/
Hipersensibilidad a las Drogas
Límite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
J. Oral Diagn
Asunto de la revista:
Medicina Bucal
/
Patologia Bucal
Año:
2023
Tipo del documento:
Article
País de afiliación:
Brasil
Pais de publicación:
Brasil